Jingjing Xing

Early tumor shrinkage and depth of response during treatment with immune checkpoint inhibitors as predictors of overall survival in patients receiving second-line or later therapy for advanced esophageal squamous cell carcinoma: a retrospective study

Early tumor shrinkage (ETS) and depth of response (DoR) reflect tumor response heterogeneity and may predict immunotherapy outcomes. This study evaluated the prognostic values of ETS and DoR in patients with advanced esophageal squamous cell carcinoma (ESCC) who received second-l...